Albert Miguela
Salt, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 13, 2026
A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.
Journal: Frontiers in immunology
Published: February 02, 2026
Intracellular complement factor H protects neurons during CNS inflammation.
Journal: Nature
Published: February 08, 2025
Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.
Journal: Multiple sclerosis and related disorders
Published: April 08, 2024
Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia Patients.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 06, 2023
Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm.
Journal: Multiple sclerosis and related disorders
Published: August 01, 2023
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report.
Journal: European journal of neurology
Published: April 25, 2023
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 19, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 27, 2022
Last Updated: 09/26/2026